drugset
drugset / Trial / NCT01598571

Study in Healthy Males to Assess Bioavailability of Single Fostamatinib With iv Micro Tracer Dose

NCT01598571 ↗

Phase 1 Completed 37 enrolled AstraZeneca
Non-randomizedSingle-groupOpen-labelBasic science

Summary

Study in healthy males to assess bioavailability of single fostamatinib with iv micro tracer dose.

Timeline

Start
2012-05
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Fostamatinib Small molecule 50 mg Oral
Subject R406 Small molecule 100 ug Intravenous

Indications

No indication recorded.